Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

Kwang Dong Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	141,839	116,189	77,344	103,552	83,966	54,882
Short-Term Investments	19,579	-	-	-	9,369	-
Trading Asset Securities	23,302	49,261	128,837	105,080	94,366	94,392
Cash & Short-Term Investments	184,720	165,450	206,181	208,632	187,701	149,273
Cash Growth	-7.17%	-19.75%	-1.18%	11.15%	25.74%	33.28%
Accounts Receivable	271,422	270,639	256,830	224,530	237,863	223,107
Other Receivables	3,462	3,773	5,513	2,734	3,568	2,874
Receivables	274,923	276,052	262,402	227,311	241,486	226,039
Inventory	193,639	217,247	188,643	161,410	152,493	171,349
Prepaid Expenses	1,889	2,350	1,766	2,017	2,370	2,868
Other Current Assets	46,345	55,762	6,432	6,376	3,769	34,966
Total Current Assets	701,516	716,862	665,424	605,747	587,818	584,494
Property, Plant & Equipment	239,208	249,038	212,432	153,532	138,013	124,679
Long-Term Investments	105,543	114,011	96,139	93,686	83,604	82,425
Goodwill	-	21,694	21,694	6,119	6,119	6,119
Other Intangible Assets	40,110	15,941	15,008	9,975	10,592	6,254
Long-Term Deferred Tax Assets	15,085	14,154	12,960	10,536	8,365	8,151
Other Long-Term Assets	58,156	37,760	52,214	50,247	46,982	17,554
Total Assets	1,162,213	1,170,275	1,078,065	932,024	883,845	830,643
Accounts Payable	157,752	169,802	171,051	174,051	153,527	156,136
Accrued Expenses	1,647	1,871	1,862	1,691	1,079	961.74
Short-Term Debt	208,725	208,940	187,834	113,006	93,006	83,005
Current Portion of Long-Term Debt	2,472	2,472	24,202	-	15,000	9,993
Current Portion of Leases	3,102	3,128	1,913	1,362	1,109	1,070
Current Income Taxes Payable	7,203	8,186	8,941	8,338	10,179	9,279
Current Unearned Revenue	430.19	310.94	291.6	331.8	331.4	273
Other Current Liabilities	73,387	66,589	60,714	54,786	51,263	41,470
Total Current Liabilities	454,718	461,299	456,810	353,567	325,495	302,187
Long-Term Debt	65,950	66,444	19,028	21,962	21,934	15,000
Long-Term Leases	4,096	4,938	2,664	1,675	997.64	636.78
Long-Term Deferred Tax Liabilities	4,019	4,440	2,173	1,675	2,717	5,735
Other Long-Term Liabilities	13,165	14,888	9,344	6,099	5,457	4,891
Total Liabilities	545,495	552,008	490,018	384,978	356,600	328,462
Common Stock	52,421	52,421	52,421	52,421	52,421	52,421
Additional Paid-In Capital	58,194	58,171	55,299	55,277	55,223	55,223
Retained Earnings	522,727	520,907	485,155	453,838	433,215	411,806
Treasury Stock	-57,488	-57,124	-53,057	-46,822	-46,822	-46,822
Comprehensive Income & Other	1,391	4,747	4,798	2,616	5,140	5,033
Total Common Equity	577,244	579,122	544,616	517,331	499,177	477,661
Minority Interest	39,475	39,145	43,431	29,716	28,068	24,520
Shareholders' Equity	616,719	618,267	588,047	547,046	527,245	502,182
Total Liabilities & Equity	1,162,213	1,170,275	1,078,065	932,024	883,845	830,643
Total Debt	284,345	285,921	235,641	138,006	132,046	109,705
Net Cash (Debt)	-99,625	-120,471	-29,460	70,627	55,655	39,568
Net Cash Growth	-	-	-	26.90%	40.66%	-
Net Cash Per Share	-2501.34	-3009.75	-727.94	1719.22	1353.21	976.33
Filing Date Shares Outstanding	39.28	39.34	40.08	41.08	41.08	41.08
Total Common Shares Outstanding	39.28	39.34	40.08	41.08	41.08	41.08
Working Capital	246,798	255,563	208,615	252,180	262,323	282,307
Book Value Per Share	14695.39	14719.33	13588.02	12593.06	12151.16	11627.42
Tangible Book Value	537,134	541,487	507,915	501,237	482,467	465,288
Tangible Book Value Per Share	13674.28	13762.78	12672.32	12201.30	11744.38	11326.22
Land	-	62,710	74,423	65,921	65,840	52,823
Buildings	-	150,395	95,003	77,283	75,616	73,146
Machinery	-	157,259	152,469	129,099	124,756	120,231
Construction In Progress	-	40,678	52,582	23,534	5,237	1,725

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.